Esperion Therapeutics, Inc. Analysis
| Analyst Ratings |
|
Average Target Price
|
11.00
|
|
Average Rating
|
3.27
|
|
# Strong Buys
|
2
|
|
# Buys
|
3
|
|
# Holds
|
3
|
|
# Sells
|
2
|
|
# Strong Sells
|
1
|
| Quarterly Earnings History |
| Quarter |
EPS Estimate |
EPS Actual |
EPS Difference |
Surprise Percent |
|
2022-09-30
|
-0.92
|
-0.81
|
0.11
|
11.96%
|
|
2022-06-30
|
-0.93
|
-1.05
|
-0.12
|
-12.90%
|
|
2022-03-31
|
-1.04
|
-0.93
|
0.11
|
10.58%
|
|
2021-12-31
|
-2.27
|
-1.77
|
0.50
|
22.03%
|
|
2021-09-30
|
-2.80
|
-2.62
|
0.18
|
6.43%
|
|
2021-06-30
|
-1.84
|
-1.67
|
0.17
|
9.24%
|
|
2021-03-31
|
-2.52
|
-3.50
|
-0.98
|
-38.89%
|
|
2020-12-31
|
-3.76
|
-3.89
|
-0.13
|
-3.46%
|
| Annual Earnings History |
| Fiscal Year End |
EPS |
|
2022-12-31
|
-2.79
|
|
2021-12-31
|
-9.56
|
|
2020-12-31
|
-5.48
|
|
2019-12-31
|
-3.72
|
|
2018-12-31
|
-7.54
|
|
2017-12-31
|
-7.02
|
|
2016-12-31
|
-3.33
|
|
2015-12-31
|
-2.26
|
|
2014-12-31
|
-2.24
|
|
2013-12-31
|
-20.79
|